ERD

Distinct transduction of muscle tissue in mice after systemic delivery of AAVpo1 vectors

Project: MYOCURE

Updated at: 29-04-2024

Show more information

Project acronym MYOCURE

AAV-mediated Sirt1 overexpression in skeletal muscle activates oxidative capacity but does not prevent insulin resistanc...

Project: MYOCURE

Updated at: 29-04-2024

Show more information

Project acronym MYOCURE

Next-generation muscle-directed gene therapy by in silico vector design

Project: MYOCURE

Updated at: 29-04-2024

Show more information

Project acronym MYOCURE

Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients

Project: MYOCURE

Updated at: 29-04-2024

Show more information

Project acronym MYOCURE

Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution

Project: MYOCURE

Updated at: 29-04-2024

Show more information

Project acronym MYOCURE

Project website

Project: MYOCURE

Updated at: 29-04-2024

Show more information

Project acronym MYOCURE

Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs

Project: MYOCURE

Updated at: 29-04-2024

Show more information

Project acronym MYOCURE

Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase

Project: MYOCURE

Updated at: 29-04-2024

Show more information

Project acronym MYOCURE

Exposure to wild-type AAV drives distinct capsid immunity profiles in humans

Project: MYOCURE

Updated at: 29-04-2024

Show more information

Project acronym MYOCURE

AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neona...

Project: MYOCURE

Updated at: 29-04-2024

Show more information

Project acronym MYOCURE

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re...

Project: MYOCURE

Updated at: 29-04-2024

Show more information

Project acronym MYOCURE

FGF21 gene therapy as treatment for obesity and insulin resistance

Project: MYOCURE

Updated at: 29-04-2024

Show more information

Project acronym MYOCURE

Periodic Reporting for period 3 - MYOCURE (Development of an innovative gene therapy platform to cure rare hereditary mu...

Project: MYOCURE

Updated at: 28-07-2022

Show more information

Project acronym MYOCURE

Resources

Selected filters:

Distinct transduction of muscle tissue in mice after systemic delivery of AAVpo1 vectors

AAV-mediated Sirt1 overexpression in skeletal muscle activates oxidative capacity but does not prevent insulin resistanc...

Next-generation muscle-directed gene therapy by in silico vector design

Long-term exposure to Myozyme results in a decrease of anti-drug antibodies in late-onset Pompe disease patients

Small But Increasingly Mighty: Latest Advances in AAV Vector Research, Design, and Evolution

Project website

Long-Term Efficacy and Safety of Insulin and Glucokinase Gene Therapy for Diabetes: 8-Year Follow-Up in Dogs

Rescue of Pompe disease in mice by AAV-mediated liver delivery of secretable acid α-glucosidase

Exposure to wild-type AAV drives distinct capsid immunity profiles in humans

AAV Gene Transfer with Tandem Promoter Design Prevents Anti-transgene Immunity and Provides Persistent Efficacy in Neona...

Antigen-selective modulation of AAV immunogenicity with tolerogenic rapamycin nanoparticles enables successful vector re...

FGF21 gene therapy as treatment for obesity and insulin resistance

Periodic Reporting for period 3 - MYOCURE (Development of an innovative gene therapy platform to cure rare hereditary mu...